[go: up one dir, main page]

HU173242B - Process for producing new prostaglandine analogues - Google Patents

Process for producing new prostaglandine analogues

Info

Publication number
HU173242B
HU173242B HU75MA2725A HUMA002725A HU173242B HU 173242 B HU173242 B HU 173242B HU 75MA2725 A HU75MA2725 A HU 75MA2725A HU MA002725 A HUMA002725 A HU MA002725A HU 173242 B HU173242 B HU 173242B
Authority
HU
Hungary
Prior art keywords
producing new
prostaglandine
analogues
prostaglandine analogues
producing
Prior art date
Application number
HU75MA2725A
Other languages
Hungarian (hu)
Inventor
Barbara J Broughton
Michael P L Caton
Edward C J Coffee
Peter J R Warren
Original Assignee
May & Baker Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by May & Baker Ltd filed Critical May & Baker Ltd
Publication of HU173242B publication Critical patent/HU173242B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056Esters of arylalkanephosphonic acids
    • C07F9/4059Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/347Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups
    • C07C51/377Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups
    • C07C51/38Preparation of carboxylic acids or their salts, halides or anhydrides by reactions not involving formation of carboxyl groups by splitting-off hydrogen or functional groups; by hydrogenolysis of functional groups by decarboxylation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10Oxygen atoms
    • C07D309/12Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HU75MA2725A 1974-11-01 1975-10-31 Process for producing new prostaglandine analogues HU173242B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB47400/74A GB1521688A (en) 1974-11-01 1974-11-01 Cyclopentane derivatives

Publications (1)

Publication Number Publication Date
HU173242B true HU173242B (en) 1979-03-28

Family

ID=10444827

Family Applications (1)

Application Number Title Priority Date Filing Date
HU75MA2725A HU173242B (en) 1974-11-01 1975-10-31 Process for producing new prostaglandine analogues

Country Status (14)

Country Link
JP (1) JPS51125255A (en)
AU (1) AU499154B2 (en)
BE (1) BE835168A (en)
CH (1) CH611601A5 (en)
DE (1) DE2548955A1 (en)
DK (1) DK492475A (en)
FI (1) FI753055A (en)
FR (1) FR2342062A1 (en)
GB (1) GB1521688A (en)
HU (1) HU173242B (en)
LU (1) LU73701A1 (en)
NL (1) NL7512816A (en)
SE (1) SE7512205L (en)
ZA (1) ZA756875B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695647A (en) * 1984-03-22 1987-09-22 Drug Science Foundation Aromatic derivatives of 13-azaprostanoic acid
WO1998058911A2 (en) * 1997-06-23 1998-12-30 Pfizer Inc. Prostaglandin agonists
EP1661580B1 (en) 2003-07-25 2014-01-08 Ono Pharmaceutical Co., Ltd. Remedy for cartilage-related diseases

Also Published As

Publication number Publication date
FR2342062B1 (en) 1979-09-21
GB1521688A (en) 1978-08-16
DK492475A (en) 1976-05-02
SE7512205L (en) 1976-05-03
NL7512816A (en) 1976-05-04
FI753055A (en) 1976-05-02
FR2342062A1 (en) 1977-09-23
DE2548955A1 (en) 1976-05-13
CH611601A5 (en) 1979-06-15
ZA756875B (en) 1977-06-29
AU8625075A (en) 1977-05-26
LU73701A1 (en) 1976-08-13
BE835168A (en) 1976-04-30
JPS51125255A (en) 1976-11-01
AU499154B2 (en) 1979-04-05

Similar Documents

Publication Publication Date Title
HU172653B (en) Process for producing substituted 2-bracket-2-pyridyl-methyl-sulfinyl-bracket closed-benzimidazols
HU172538B (en) Process for producing methyl-5-propylthio-2-benzimidazolecarbamates
HU173052B (en) Process for producing thienyl-urea derivatives
HU172039B (en) Process for producing 2-phenyl-indole derivatives
HU171867B (en) Process for producing 2-arylamino-imidazoline derivatives
HU172906B (en) Process for producing alkyl-amino-glykopyranozide derivatives
HU173365B (en) Process for producing olefine-polimers
HU172841B (en) Method for producing amino-carboxylic-acid-esters
HU172103B (en) Process for producing 2-3-cyanoimino-3-amino-propionitrile derivatives
YU44833B (en) Process for producing 1-carboxyalkyltetrazol-5-thiole
HU171512B (en) Process for producing nicotinamide-adenine-dinukleotide derivatives
HU174252B (en) Process for producing new aminophenylethers
HU172652B (en) Process for producing substituted 1-alkylamino-3-aryloxy-propan-2-ols
HU173609B (en) Process for producing new sallicylanilide derivatives
HU175541B (en) Process for producing 2-anilino-oxazolines
JPS52102258A (en) Process for preparing prostaglandine precursor
HU173390B (en) Process for producing new benzylamine derivatives
HU173890B (en) Process for producing new n-buthyl-amine derivatives
HU173242B (en) Process for producing new prostaglandine analogues
HU174061B (en) Process for producing 5-nitro-imidazoles
HU172651B (en) Process for producing substituted 3-bracket-2-bracket closed-4-hydroxy-phenyl-bracket-ethylamino-bracket closed-phenoxy-alkan-2-ols
YU326975A (en) Process for producing new dianhydro-hexyte derivatives
BG27236A3 (en) Production method for 3- methylcepnamsulfoxides
HU173669B (en) Process for producing prostaglandine derivatives
HU173551B (en) Process for producing 7-mono-bracket-0-beta-hydroxyethyl-bracket closed-rutozid